These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 39331392)
1. Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl. Thakrar AP; Christine PJ; Siaw-Asamoah A; Spadaro A; Faude S; Snider CK; Delgado MK; Lowenstein M; Kampman K; Perrone J; Nelson LS; Kilaru AS JAMA Netw Open; 2024 Sep; 7(9):e2435895. PubMed ID: 39331392 [TBL] [Abstract][Full Text] [Related]
2. Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal. D'Onofrio G; Herring AA; Perrone J; Hawk K; Samuels EA; Cowan E; Anderson E; McCormack R; Huntley K; Owens P; Martel S; Schactman M; Lofwall MR; Walsh SL; Dziura J; Fiellin DA JAMA Netw Open; 2024 Jul; 7(7):e2420702. PubMed ID: 38976265 [TBL] [Abstract][Full Text] [Related]
3. Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial. Nunes EV; Comer SD; Lofwall MR; Walsh SL; Peterson S; Tiberg F; Hjelmstrom P; Budilovsky-Kelley NR JAMA Netw Open; 2024 Jun; 7(6):e2417377. PubMed ID: 38916892 [TBL] [Abstract][Full Text] [Related]
4. Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study. Jones BLH; Geier M; Neuhaus J; Coffin PO; Snyder HR; Soran CS; Knight KR; Suen LW Harm Reduct J; 2024 Apr; 21(1):80. PubMed ID: 38594721 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial. Dunn KE; Tompkins DA; Bigelow GE; Strain EC JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791 [TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial of a 16 mg vs 24 mg maintenance daily dose of buprenorphine to increase retention in treatment among people with an opioid use disorder in Rhode Island: study protocol paper. Armeni K; Chambers LC; Peachey A; Berk J; Langdon KJ; Peterson L; Beaudoin FL; Wightman RS BMJ Open; 2024 Nov; 14(11):e085888. PubMed ID: 39521460 [TBL] [Abstract][Full Text] [Related]
7. Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence. Wakeman SE; Chang Y; Regan S; Yu L; Flood J; Metlay J; Rigotti N J Addict Med; 2019; 13(4):253-257. PubMed ID: 30550392 [TBL] [Abstract][Full Text] [Related]
8. Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit. Weiner SG; Little K; Yoo J; Flores DP; Hildebran C; Wright DA; Ritter GA; El Ibrahimi S JAMA Netw Open; 2024 Jul; 7(7):e2423954. PubMed ID: 39037812 [TBL] [Abstract][Full Text] [Related]
9. Buprenorphine for managing opioid withdrawal. Gowing L; Ali R; White JM; Mbewe D Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474 [TBL] [Abstract][Full Text] [Related]
10. Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine. Bormann NL; Gout A; Kijewski V; Lynch A F1000Res; 2022; 11():487. PubMed ID: 37767082 [No Abstract] [Full Text] [Related]
11. Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report. Christian NJ; Butner JL; Evarts MS; Weimer MB J Addict Med; 2023 Jul-Aug 01; 17(4):488-490. PubMed ID: 37579118 [TBL] [Abstract][Full Text] [Related]
12. A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine. Tompkins DA; Smith MT; Mintzer MZ; Campbell CM; Strain EC J Pharmacol Exp Ther; 2014 Feb; 348(2):217-26. PubMed ID: 24227768 [TBL] [Abstract][Full Text] [Related]
13. Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization. Axeen S; Pacula RL; Merlin JS; Gordon AJ; Stein BD JAMA Netw Open; 2024 Sep; 7(9):e2435478. PubMed ID: 39320889 [TBL] [Abstract][Full Text] [Related]
14. Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review. Englander H; Thakrar AP; Bagley SM; Rolley T; Dong K; Hyshka E JAMA Intern Med; 2024 Jun; 184(6):691-701. PubMed ID: 38683591 [TBL] [Abstract][Full Text] [Related]
15. Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting. Spadaro A; Long B; Koyfman A; Perrone J Am J Emerg Med; 2022 Aug; 58():22-26. PubMed ID: 35623179 [TBL] [Abstract][Full Text] [Related]
16. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge. Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457 [TBL] [Abstract][Full Text] [Related]
17. Ketamine-assisted buprenorphine initiation: a pilot case series. Grande LA; Hutch T; Jack K; Mironov W; Iwuoha J; Muy-Rivera M; Grillo J; Martin SA; Herring A Addict Sci Clin Pract; 2024 Aug; 19(1):60. PubMed ID: 39210398 [TBL] [Abstract][Full Text] [Related]
18. Tranq Dope: Characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl/xylazine. London K; Li Y; Kahoud JL; Cho D; Mulholland J; Roque S; Stugart L; Gillingham J; Borne E; Slovis B Am J Emerg Med; 2024 Nov; 85():130-139. PubMed ID: 39260041 [TBL] [Abstract][Full Text] [Related]
19. Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial. Walsh SL; Comer SD; Lofwall MR; Vince B; Levy-Cooperman N; Kelsh D; Coe MA; Jones JD; Nuzzo PA; Tiberg F; Sheldon B; Kim S JAMA Psychiatry; 2017 Sep; 74(9):894-902. PubMed ID: 28655025 [TBL] [Abstract][Full Text] [Related]
20. Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series. Adams KK; Cohen SM; Guerra ME; Weimer MB J Addict Med; 2023 Jul-Aug 01; 17(4):474-476. PubMed ID: 37579114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]